Eight of the 30 Dow components lost value in 2024. Here's a quick look at each company, to help you determine which dividend ...

But the Dow Jones Industrial Average (DJINDICES ... making it the second most valuable U.S.-based healthcare company behind Eli Lilly. The stock got pummeled in December due to controversy ...

In the latest trading session, Eli Lilly (LLY) closed at $753.98, marking a +1.57% move from the previous day. This move outpaced the S&P 500's daily gain of 0.61%. Meanwhile, the Dow gained 0.3% ...

The Danish drug company said an experimental weight-loss shot helped patients lose over one-fifth of their bodyweight. Novo's U.S. and [Europe-listed s ...

Shares of Eli Lilly were taking a 6.9% hit toward a two-month low in recent trading, enough to make them the S&P 500's biggest decliner. The problem is that the drug giant provided fourth-quarter ...

In the latest trading session, Eli Lilly (LLY) closed at $753.98, marking a +1.57% move from the previous day. This move outpaced the S&P 500's daily gain of 0.61%. Meanwhile, the Dow gained 0.3%, and ...

US PMI data came in more mixed than expected, to little effect. The Dow Jones Industrial Average (DJIA) churned into a soft backpedal on Friday, testing down around 200 points on a slow trading day.

Tariff threats from the White House are still leaking through, now for February. The Dow Jones Industrial Average (DJIA) absorbed newly-minted President Donald Trump’s last-minute pivot away ...

The Dow Jones rallied on the stock market today. A Donald Trump stock dived while Cathie Wood snapped up a plunging AI stock.

Argus Research analyst Jasper Hellweg maintained a Buy rating on Eli Lilly & Co (LLY – Research Report) yesterday. The company’s shares ...

Bank of America Securities analyst Tim Anderson maintained a Buy rating on Eli Lilly & Co (LLY – Research Report) today. The company’s ...